Showing results (81-90 of 1,914) with videos related to
Sort By:
Pageof 192
Biomaterials, Medical Devices, and Artificial Organs|January 1, 1983
Albuminated polymer surfaces for biomedical applicationR Sipehia, A S ChawlaSeminars in Oncology|March 4, 2000
Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neckD M ShinJournal of the Indian Society of Pedodontics and Preventive Dentistry|May 6, 2009
Orthodontic management of faciolingual horizontally impacted maxillary central incisorH S Chawla, A KapurAnnals of Internal Medicine|May 1, 1978
Ovarian (corpus luteum) hemorrhage during anticoagulation therapyD D Tresch, G Halverson, M Blick, et al.Developmental Biology|December 5, 2006
Sox2 and Pou2f1 interact to control lens and olfactory placode developmentAmy L Donner, Vasso Episkopou, Richard L MaasScandinavian Journal of Haematology|September 1, 1977
Serum thrombopoietic activity following administration of vinblastineP Klener, O Marcibal, L Donner, et al.Journal of Biomolecular Structure & Dynamics|May 22, 2012
Role of the N- and C- terminal dimer interfaces of 434 repressor in recognizing sequence-dependent DNA structureG B Koudelka, A L Donner, M CiubotaruMetabolism: Clinical and Experimental|February 1, 1981
Effects of interferon on the cAMP-adenylate cyclase system of human, mouse, and bovine thyroid tissueS D Holmes, M Chou, J Gutterman, et al.Folia Biologica|January 1, 1975
Treatment of RSV-transformed "poorly" virogenic and non-virogenic mammalian cell lines with inhibitors of protein synthesis: failure to potentiate RSV rescueL Donner, H Sainerová, J Svoboda, et al.Journal of Molecular Biology|November 4, 1998
Carboxyl-terminal domain dimer interface mutant 434 repressors have altered dimerization and DNA binding specificitiesA L Donner, K Paa, G B KoudelkaPageof 192